High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration.

CONCLUSIONS: Increasing the dose of bevacizumab in refractory PED may be a possible treatment option.
PMID: 27478353 [PubMed - in process]

Source: Korean Journal of Ophthalmology : KJO - August 3, 2016 Category: Opthalmology Tags: Korean J Ophthalmol Source Type: research